BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 29969320)

  • 21. Effect of Antibiotic Discontinuation Strategies on Mortality and Infectious Complications in Critically Ill Septic Patients: A Meta-Analysis and Trial Sequential Analysis.
    Arulkumaran N; Khpal M; Tam K; Baheerathan A; Corredor C; Singer M
    Crit Care Med; 2020 May; 48(5):757-764. PubMed ID: 32191414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
    Albrich WC; Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Bachli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Gaillat J; Schuetz P; Regez K; Bossart R; Schild U; Mueller B;
    Arch Intern Med; 2012 May; 172(9):715-22. PubMed ID: 22782201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis.
    Soni NJ; Samson DJ; Galaydick JL; Vats V; Huang ES; Aronson N; Pitrak DL
    J Hosp Med; 2013 Sep; 8(9):530-40. PubMed ID: 23955852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials.
    Wirz Y; Meier MA; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Schroeder S; Nobre V; Annane D; Reinhart K; Damas P; Nijsten M; Shajiei A; deLange DW; Deliberato RO; Oliveira CF; Shehabi Y; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Mueller B; Schuetz P
    Crit Care; 2018 Aug; 22(1):191. PubMed ID: 30111341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of procalcitonin in guiding antibiotic therapy.
    Fazili T; Endy T; Javaid W; Maskey M
    Am J Health Syst Pharm; 2012 Dec; 69(23):2057-61. PubMed ID: 23172263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis.
    Schuetz P; Bretscher C; Bernasconi L; Mueller B
    Expert Rev Mol Diagn; 2017 Jun; 17(6):593-601. PubMed ID: 28443360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective.
    Stojanovic I; Schneider JE; Wei L; Hong Z; Keane C; Schuetz P
    Clin Chem Lab Med; 2017 Mar; 55(4):561-570. PubMed ID: 27658150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
    Sager R; Kutz A; Mueller B; Schuetz P
    BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
    Schuetz P; Briel M; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Mueller B
    Clin Infect Dis; 2012 Sep; 55(5):651-62. PubMed ID: 22573847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
    Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
    Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions.
    Wirz Y; Branche A; Wolff M; Welte T; Nobre V; Reinhart K; Falsey AR; Damas P; Beishuizen A; Deliberato RO; Shehabi Y; Jensen JS; Mueller B; Schuetz P
    ACS Infect Dis; 2017 Dec; 3(12):875-879. PubMed ID: 29120606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
    Schuetz P; Balk R; Briel M; Kutz A; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Lacey MJ; Ohsfeldt RL; Scheibling CM; Schneider JE
    Clin Chem Lab Med; 2015 Mar; 53(4):583-92. PubMed ID: 25581762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections.
    Schuetz P; Briel M; Mueller B
    JAMA; 2013 Feb; 309(7):717-8. PubMed ID: 23423417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do we need new trials of procalcitonin-guided antibiotic therapy?
    Lisboa T; Salluh J; Povoa P
    Crit Care; 2018 Jan; 22(1):17. PubMed ID: 29373980
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.